Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramzi A Ajjan

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Diabetes & Vascular Disease Research|September 4, 2012
Primary and secondary prevention of cardiovascular disease in diabetes with aspirinRamzi A Ajjan
Diabetes Technology & Therapeutics|May 26, 2017
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?Ramzi A Ajjan
Molecular Immunology|August 11, 2019
Role of complement in diabetesRamzi A Ajjan, Verena Schroeder
Frontiers in Cardiovascular Medicine|February 7, 2018
Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic TargetsNikoletta Pechlivani, Ramzi A Ajjan
Expert Review of Endocrinology & Metabolism|February 13, 2019
New insights into antibody-mediated hyperthyroidismRamzi A Ajjan, Anthony P Weetman
Expert Opinion on Drug Safety|July 11, 2008
The cardiovascular safety of rosiglitazoneRamzi A Ajjan, Peter J Grant
Diabetes & Vascular Disease Research|December 13, 2016
Vascular risk in obesity: Facts, misconceptions and the unknownRhodri J King, Ramzi A Ajjan
Diabetes & Vascular Disease Research|December 13, 2006
Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agentsRamzi A Ajjan, Peter J Grant
Expert Review of Cardiovascular Therapy|November 19, 2005
Role of clotting factors and fibrin structure in predisposition to atherothrombotic diseaseRamzi A Ajjan, Peter J Grant
Diabetes Technology & Therapeutics|December 13, 2017
Flash Glucose Monitoring in Younger Individuals with Diabetes: Accuracy and Patient Experience in Real-World SettingsSam Matthew Pearson, Ramzi A Ajjan
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Diabetes & Vascular Disease Research|September 4, 2012
Primary and secondary prevention of cardiovascular disease in diabetes with aspirinRamzi A Ajjan
Diabetes Technology & Therapeutics|May 26, 2017
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?Ramzi A Ajjan
Molecular Immunology|August 11, 2019
Role of complement in diabetesRamzi A Ajjan, Verena Schroeder
Frontiers in Cardiovascular Medicine|February 7, 2018
Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic TargetsNikoletta Pechlivani, Ramzi A Ajjan
Expert Review of Endocrinology & Metabolism|February 13, 2019
New insights into antibody-mediated hyperthyroidismRamzi A Ajjan, Anthony P Weetman
Expert Opinion on Drug Safety|July 11, 2008
The cardiovascular safety of rosiglitazoneRamzi A Ajjan, Peter J Grant
Diabetes & Vascular Disease Research|December 13, 2016
Vascular risk in obesity: Facts, misconceptions and the unknownRhodri J King, Ramzi A Ajjan
Diabetes & Vascular Disease Research|December 13, 2006
Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agentsRamzi A Ajjan, Peter J Grant
Expert Review of Cardiovascular Therapy|November 19, 2005
Role of clotting factors and fibrin structure in predisposition to atherothrombotic diseaseRamzi A Ajjan, Peter J Grant
Diabetes Technology & Therapeutics|December 13, 2017
Flash Glucose Monitoring in Younger Individuals with Diabetes: Accuracy and Patient Experience in Real-World SettingsSam Matthew Pearson, Ramzi A Ajjan
Pageof 16